 |
Arbutus Biopharma Corporation
ABUS
|
31.5 |
$ 4.79 |
2.35 % |
$ 795 M |
Canada |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Aclaris Therapeutics
ACRS
|
6.01 |
$ 3.04 |
4.83 % |
$ 235 M |
USA |
 |
Alpine Immune Sciences
ALPN
|
154 |
- |
- |
$ 2.17 B |
USA |
 |
Aptorum Group Limited
APM
|
20.6 |
$ 1.17 |
4.46 % |
$ 6.38 M |
China |
 |
Aptevo Therapeutics
APVO
|
79 |
$ 0.93 |
-8.81 % |
$ 257 K |
USA |
 |
Athersys
ATHX
|
22.6 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
49.5 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
6.09 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
103 |
- |
-7.31 % |
$ 87 M |
USA |
 |
bluebird bio
BLUE
|
2.47 |
- |
- |
$ 546 M |
USA |
 |
Calithera Biosciences
CALA
|
28.8 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 0.18 |
-25.03 % |
$ 392 M |
Israel |
 |
Catalyst Biosciences
CBIO
|
3.24 |
$ 12.37 |
2.06 % |
$ 814 M |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.1 |
0.16 % |
$ 7.46 B |
Australia |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
25 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
Celsion Corporation
CLSN
|
15.6 |
- |
-6.63 % |
$ 13.9 M |
USA |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Corcept Therapeutics Incorporated
CORT
|
25.7 |
$ 83.59 |
1.95 % |
$ 8.63 B |
USA |
 |
Catalyst Pharmaceuticals
CPRX
|
44.2 |
$ 24.45 |
0.91 % |
$ 2.9 B |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
62.6 |
$ 26.81 |
1.36 % |
$ 1.3 B |
USA |
 |
Anika Therapeutics
ANIK
|
77.3 |
$ 9.48 |
0.96 % |
$ 139 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
52.1 |
- |
- |
$ 1.2 B |
USA |
 |
Arena Pharmaceuticals
ARNA
|
946 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Axon Enterprise
AXON
|
134 |
$ 591.15 |
0.02 % |
$ 44.8 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Aytu BioScience
AYTU
|
150 |
$ 2.53 |
-0.39 % |
$ 15.9 M |
USA |
 |
Celldex Therapeutics
CLDX
|
86.5 |
$ 26.83 |
0.94 % |
$ 1.73 M |
USA |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |